Ritonavir API: High-Purity Pharmaceutical Ingredient for Advanced Drug Formulations
Unlock enhanced therapeutic efficacy with our premium Ritonavir API, a cornerstone for critical antiviral treatments.
Get a Quote & SampleProduct Core Value
Ritonavir
Ritonavir is a critical active pharmaceutical ingredient (API) with a CAS number of 155213-67-5. It is renowned for its high purity, exceeding 99%, and its distinctive white crystalline powder appearance. Primarily known as a potent protease inhibitor and pharmacokinetic enhancer, Ritonavir plays a vital role in enhancing the effectiveness of other antiviral medications, particularly in the treatment of HIV/AIDS and Hepatitis C.
- Ritonavir API 155213-67-5: Essential for formulating advanced antiviral medications, offering high purity for consistent therapeutic outcomes.
- High Purity Ritonavir for Export: Sourced and processed to meet stringent international pharmaceutical standards, ensuring quality for global markets.
- Pharmaceutical Grade Ritonavir: This active pharmaceutical ingredient is vital for drug development, supporting the creation of effective treatments for complex viral infections.
- Ritonavir as a CYP3A4 Inhibitor: Its significant role in inhibiting the CYP3A4 enzyme allows for boosted concentrations of co-administered drugs, maximizing therapeutic benefits.
Advantages Offered by the Product
Enhanced Potency
As a potent Ritonavir CYP3A4 inhibitor, it significantly boosts the plasma concentrations of other protease inhibitors, leading to improved treatment efficacy.
Broad Therapeutic Application
The Ritonavir active pharmaceutical ingredient is fundamental in the treatment regimens for HIV/AIDS and Hepatitis C, with growing relevance in Ritonavir COVID-19 treatment research.
Quality Assurance
Our commitment to providing high purity Ritonavir for export ensures that pharmaceutical manufacturers receive a reliable ingredient for their drug formulations.
Key Applications
HIV/AIDS Treatment
Used as a pharmacokinetic enhancer to boost the efficacy of other antiretroviral drugs, contributing to effective HIV/AIDS management.
Hepatitis C Treatment
Essential component in combination therapies for Hepatitis C, helping to maintain effective drug levels.
COVID-19 Research
Investigated for its role in combination therapies for COVID-19, leveraging its ability to increase the blood concentration of antiviral agents.
Drug Development
The pharmaceutical grade Ritonavir serves as a vital building block for new drug formulations and research into novel therapeutic agents.